Australia's most trusted
source of pharma news
Wednesday, 18 March 2026
Wednesday, 18 March 2026
Subscribe
Login
'Bad juju' crashes Aussie company
Three months after inking a deal worth more than half-a-billion dollars in milestone payments, this Sydney company has lost 90 per cent of its share price in circumstances described by one financial analyst as 'bad juju'.
Locals improve CAR T therapy
The TGA has approved trials for a CAR T-cell therapy targeting a different receptor, improving the safety profile of the treatment
TODAY
World's top drug, by a loophole
This drug brought in a handsome haul last year and seemed to be holding a comfortable lead but was it a win on a technicality?
TODAY
Arrotex inks cardio drug deal
Aussie duo aims to commercialise a new triplet combo therapy for hypertension in Australia and New Zealand as early as next year
17 March
Novo CEO taps Australia to lead
Before shaking hands with Danish Royalty, Novo CEO Mike Doustdar touted an 'Australian-made' solution to the obesity epidemic
17 March
12 drugs in PBS limbo pileup
Twelve drugs that secured a recommendation at the PBAC's November 2025 meeting have stalled in the PBS listing process
16 March
CEO pay packet rockets by 75%
In his second year in the job, this big pharma CEO has hit the big league, with his compensation package soaring
16 March
Latest Jobs
Corporate Operations ManagerWarehouse AssistantCustomer Service RepresentativePractice ManagerAccount ManagerRegulatory Affairs SpecialistBusiness Development Manager | Community CareDirector of Operations19 more...
Pharma in Focus Jobs
Sales & Customer Relations (9)
- Customer Service Representative - St Leonards
- Account Manager - Sydney
- Business Development Manager | Community Care - Queensland
- Pharmaceutical Sales Representative - Sydney
- Devices Account Manager - Sydney
- Customer Service Representative - Pemulwuy
- Customer Service Representative - St Leonards
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Specialist - Frenchs Forest
Clinical & Medical, R&D (2)
- Senior Clinical Project Manager - Tokyo, Japan
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (6)
- Regulatory Affairs Specialist - Lane Cove
- Regulatory Affairs Specialist - Glenorie
- Pharmacovigilance Associate - Sydney
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Regulatory & Quality Manager - Melbourne
Devices (1)
Executive Roles (4)
- Director of Operations - Melbourne
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
Other (10)
- Corporate Operations Manager - Sydney, NSW
- Warehouse Assistant - Macquarie Park
- Practice Manager - Sydney
- Senior Recruitment Consultant - Sydney
- Pharmacy Storeperson - Toongabbie
- Warehouse Assistant - Eight Mile Plains
- Materials Planner - North Ryde
- Procurement Specialist - New South Wales
- Finance & Administration Officer - Macquarie Park
- Re-manufacturing Operator - New South Wales
PBAC lets slip reason for 'go-slow'
The PBAC has revealed why it is dragging its heels in recommending a much-in-demand class of drugs, instead aiming for a "slow roll-out"
TODAY
Australia lines up for RNA first
US company hopes to secure approval for its lead product in Australia within the next 12 months, and in other major markets in 2027
TODAY
Meet pharma's newest blockbuster
A still-growing dual inhibitor almost quadrupled annual sales to scream into blockbuster territory, and it's showing up in PBS reimbursements
17 March
Seqirus takes jab to private market
Just in time for the upcoming flu season, CSL Seqirus has won TGA approval for its influenza vaccine in a younger adult cohort
17 March
Novartis quizzes Aussies on MS
National survey lifts the lid on entrenched public misconceptions about the condition with some alarming findings taking their toll
17 March
GSK tops Kosi fundraising peak
Industry rose to the challenge to help raise record funds for rare cancer by scaling Australia's tallest mountain
16 March
Dept seeks expansion for big drugs
The DoH has asked PBAC to expand two blockbuster drugs, moving them to the first line, after a sponsor was knocked back
16 March
$57M J&J drug under threat
The TGA has approved the first generic of this J&J PBS listed drug while a second generic brand circles a BioMarin's medicine
16 March Approvals Action
Minister wins blockbuster price cut case
Gilead has lost a court battle to protect three drugs earning $164 million a year from follow-on statutory price cuts
13 March
Last ditch effort to keep exclusivity
Stage set for a High Court showdown over a ruling that has shortened exclusivity for a swath of drugs across the industry
13 March
New drug disappears from PBS
ICYMI: The disappearing act of a first-in-class PBS drug listed for just 14 months plus the other most popular stories this week
13 March Your Week in 5 Minutes
PBS is "like handwriting letters"
AbbVie GM tells a future leadership summit that PBS processes are stuck deep in the past, blocking access to scientific advances
13 March
Pain Institute launches in Australia
Bringing together clinical and academic expertise to develop ways to support HCPs and patients improve pain outcomes
13 March
CEO flying in for Aussie TV spot
In a televised address, Novo CEO Mike Doustdar will appeal to Australia to take a leadership role in the global effort to prevent chronic disease
12 March